Leverage your data to drive clinical outcomes
Accelerate innovation with real world data
Log in to the OMNY Health Platform
Learn more about OMNY Health
Join our rapidly growing team
Meet our team at upcoming events
Keep up with the latest news
Keep the conversation going
On May 15 – May 18, 2022, this poster was on display at ISPOR 2022. What is the Objective of this Poster? These results help provide insights into which factors are associated with the receipt of TAVR vs. SAVR in the real-world hospital setting. After adjusting for...
On May 15 – May 18, 2022, this poster was on display at ISPOR 2022. What is the Objective of this Poster? Results help provide insights into real-world treatment patterns among children with COVID-19 in the hospital setting during the pandemic. Most therapy...
On May 15 – May 18, 2022, this poster was on display at ISPOR 2022. What is the Objective of this Poster? ADEs and ADRs represent significant burden to the healthcare system Can account for 1-5% of hospital admissions overall, and up to 10% for elderly Can occur...
On May 15 – May 18, 2022, this poster was on display at ISPOR 2022. What is the Objective of this Poster? Clinical outcomes were similar between SR and MR cohorts, including:– Mortality (% [95% confidence interval]) (1.1% [0.6%- 2.0%] vs 0.3% [0.0% - 2.0%]),–...
On May 15 – May 18, 2022, this poster was on display at ISPOR 2022. What is the Objective of this Poster? Results provide insights into real-world treatment patterns for AD within large dermatology specialty networks in the United States. As new treatments are...
On May 15 – May 18, 2022, this poster was on display at ISPOR 2022. What is the Objective of this Poster? Results provide insights into real-world treatment patters for AA within a diverse set of US healthcare settings. ILCS and TCS were by far the most common...
On May 15 – May 18, 2022, this poster was on display at ISPOR 2022. What is the Objective of this Poster? Results provide insight into characteristics and treatments of pediatric HS within a diverse set of US healthcare setting. Acne presented as the most common...
On May 15 – May 18, 2022, this poster was on display at ISPOR 2022. What is the Objective of this Poster? Results provide insights into real-world treatment patterns for HS within a diverse set of US healthcare settings. Adalimumab use has increased steadily since the...
On May 15 – May 18, 2022, this poster was on display at ISPOR 2022. What is the Objective of this Poster? We were unable to observe higher than 58% accuracy with our NLP model. Nevertheless, this analysis represents an important initial step in developing a more...
On May 15 – May 18, 2022, this poster was on display at ISPOR 2022. What is the Objective of this Poster? Results provide insights into real-world trends in use of biologics for treatment of PsA. Patient use of biologics increased steadily over the observation period...
By continuing to use the site, you agree to the use of cookies. More information.
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below, then you are consenting to this.